Home
About
Overview
Sharing Data
ORCID
Help
History (51)
Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function.
A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.
Poly A-U
Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
See All 51 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease. Am J Gastroenterol. 2000 Nov; 95(11):3150-6.
View in:
PubMed
subject areas
Adult
Biopsy
Chemical and Drug Induced Liver Injury
Colitis, Ulcerative
Crohn Disease
Female
Folic Acid Antagonists
Humans
Liver
Male
Methotrexate
Time Factors
authors with profiles
Helen Te
Stephen B. Hanauer